{"AllianceGenome": "9867", "HGNC": "9867", "MIM": "605090", "_id": "5918", "_version": 1, "accession": {"genomic": ["AC080013.17", "CH471052.2", "CP068275.2", "NC_000003.12", "NC_060927.1"], "protein": ["AAA99722.1", "AAH29640.1", "EAW78675.1", "EAW78676.1", "NP_002879.2", "NP_996846.1", "P49788.2", "XP_005247743.4", "XP_054203394.1"], "rna": ["AK130079.1", "AW514087.1", "BC029640.1", "BM919188.1", "NM_002888.4", "NM_206963.2", "U27185.1", "XM_005247686.6", "XM_054347419.1", "XR_008486768.1"], "translation": [{"protein": "XP_054203394.1", "rna": "XM_054347419.1"}, {"protein": "NP_002879.2", "rna": "NM_002888.4"}, {"protein": "NP_996846.1", "rna": "NM_206963.2"}, {"protein": "XP_005247743.4", "rna": "XM_005247686.6"}, {"protein": "AAA99722.1", "rna": "U27185.1"}, {"protein": "AAH29640.1", "rna": "BC029640.1"}]}, "alias": ["LXNL", "PERG-1", "TIG1"], "ensembl": {"gene": "ENSG00000118849", "protein": ["ENSP00000237696", "ENSP00000418556"], "transcript": ["ENST00000237696", "ENST00000462663", "ENST00000471444", "ENST00000479756", "ENST00000498640"], "translation": [{"protein": "ENSP00000237696", "rna": "ENST00000237696"}, {"protein": "ENSP00000418556", "rna": "ENST00000479756"}], "type_of_gene": "protein_coding"}, "entrezgene": "5918", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 8.32713024969, "exp_mis": 61.723982798, "exp_syn": 23.2076328841, "lof_z": -0.230979285569539, "mis_z": 0.978930776520547, "mu_lof": 8.2926768407e-07, "mu_mis": 1.14616802973e-05, "mu_syn": 5.51848949552e-06, "n_lof": 9.0, "n_mis": 46.0, "n_syn": 22.0, "p_li": 8.40651968753382e-07, "p_null": 0.832336781939524, "p_rec": 0.167662377408507, "syn_z": 0.155406065110804}, "bp": 885, "cds_end": 158450204, "cds_start": 158415466, "n_exons": 6, "nonpsych": {"exp_lof": 7.44072087238, "exp_mis": 55.7700267218, "exp_syn": 20.9090112922, "lof_z": -0.20135995144853, "mis_z": 0.930028271026282, "mu_lof": 8.2926768407e-07, "mu_mis": 1.14616802973e-05, "mu_syn": 5.51848949552e-06, "n_lof": 8.0, "n_mis": 42.0, "n_syn": 20.0, "p_li": 4.55009515808672e-06, "p_null": 0.787819861240591, "p_rec": 0.212175588664251, "syn_z": 0.125159963049996}, "nontcga": {"exp_lof": 7.65158941718, "exp_mis": 56.7766975349, "exp_syn": 21.3416520403, "lof_z": 0.232369677139979, "mis_z": 1.1753733523977, "mu_lof": 8.2926768407e-07, "mu_mis": 1.14616802973e-05, "mu_syn": 5.51848949552e-06, "n_lof": 7.0, "n_mis": 39.0, "n_syn": 22.0, "p_li": 4.49959564129737e-05, "p_null": 0.590094633157017, "p_rec": 0.40986037088657, "syn_z": -0.0902329546257726}, "transcript": "ENST00000237696.5"}, "exons": [{"cdsend": 158732415, "cdsstart": 158704775, "chr": "3", "position": [[158704650, 158704927], [158710737, 158710933], [158713796, 158713859], [158732139, 158732486]], "strand": -1, "transcript": "NM_002888", "txend": 158732486, "txstart": 158704650}, {"cdsend": 158732415, "cdsstart": 158697677, "chr": "3", "position": [[158696891, 158697827], [158697907, 158697970], [158704790, 158704927], [158710737, 158710933], [158713796, 158713859], [158732139, 158732457]], "strand": -1, "transcript": "NM_206963", "txend": 158732457, "txstart": 158696891}], "exons_hg19": [{"cdsend": 158450204, "cdsstart": 158422564, "chr": "3", "position": [[158422439, 158422716], [158428526, 158428722], [158431585, 158431648], [158449928, 158450275]], "strand": -1, "transcript": "NM_002888", "txend": 158450275, "txstart": 158422439}, {"cdsend": 158450204, "cdsstart": 158415466, "chr": "3", "position": [[158414680, 158415616], [158415696, 158415759], [158422579, 158422716], [158428526, 158428722], [158431585, 158431648], [158449928, 158450246]], "strand": -1, "transcript": "NM_206963", "txend": 158450246, "txstart": 158414680}], "generif": [{"pubmed": 15059893, "text": "Silencing of TIG1 promoter by hypermethylation is common in human cancers and may contribute to the loss of retinoic acid responsiveness in some neoplastic cells."}, {"pubmed": 16128742, "text": "results show that inactivation of the retinoic acid signaling-associated genes RAR-beta, CRBP1, and TIG1 by DNA methylation occurs frequently in esophageal squamous cell carcinoma"}, {"pubmed": 16134180, "text": "Hypermethylation of tazarotene-induced gene 1 is associated with gastric carcinogenesis"}, {"pubmed": 19250291, "text": "TIG1 overexpression in SASC inhibited their differentiation into osteocytes and the expression of osteocalcin"}, {"pubmed": 19737656, "text": "Findings suggest that TIG1 may play a role in cellular proliferation and invasion in NPC cells and that its function may be dependent on the EBV status."}, {"pubmed": 19806788, "text": "TIG1 undergoes frequent epigenetic inactivation due to aberrant DNA hypermethylation in gastric cancers."}, {"pubmed": 19834535, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21168224, "text": "The results of this study suggested that short RAI1 alleles might be releated to schizophreina disease."}, {"pubmed": 21303978, "text": "RARRES1, its interacting partners AGBL2, Eg5/KIF11, another EEY-bearing protein (EB1), and the microtubule tyrosination cycle are important in tumorigenesis."}, {"pubmed": 21575264, "text": "GRK5 mediates cell growth suppression by TIG1A. Thus, TIG1 may participate in the downregulation of G-protein coupled signaling by upregulating GRK5 expression."}, {"pubmed": 22126303, "text": "TIG1 suppressed PGE2-stimulated Wnt and cAMP signaling pathways in colon cancer cells through GRK5."}, {"pubmed": 22573467, "text": "genotype-associated hypermethylation of the ETS-family target gene RARRES1 influences methylation at its neighbor gene LXN and could be useful as a prognostic biomarker."}, {"pubmed": 22615834, "text": "Knocking-down CTCF expression hampered RARRES1 expression."}, {"pubmed": 22669512, "text": "Analysis of a standard liver fibrosis model (CCl(4)) demonstrated an early induction of RARRES1 mRNA and protein expression."}, {"pubmed": 22942771, "text": "All-trans retinoic acid modulated secretion of RARRES1 in a dose dependent manner."}, {"pubmed": 24006221, "text": "our data suggested that epigenetic silencing of TIG1 gene expression by promoter hypermethylation may play an important role in hepatocellular carcinoma ."}, {"pubmed": 24014597, "text": "High TIG1 expression is associated with inflammatory breast cancer through activation of Axl kinase."}, {"pubmed": 27286452, "text": "Data show that retinoic acid receptor responder 1 (RARRES1) expression is subtype-dependent and regulated by DNA methylation and the expression of aldehyde dehydrogenase 1A3 (ALDH1A3)."}, {"pubmed": 27989102, "text": "Authors found that transmembrane protein 192 (TMEM192) interacted with TIG1. Authors also found that both TIG1A and TIG1B isoforms interacted and co-localized with TMEM192 in HtTA cervical cancer cells. The expression of TIG1 induced the expression of autophagy-related proteins."}, {"pubmed": 28678839, "text": "Data suggest that Retinoic Acid Receptor Responder (RARRES1)/ Tazarotene-induced gene-1 (TIG-1) may serve as a target for therapeutic intervention both in cancer and in angiogenesis-related disorders."}, {"pubmed": 29169400, "text": "Data demonstrated that RARRES1 expression is lost in choriocarcinoma tumors due to promotor hypermethylation. Also, further results hypothesized that RARRES1 might be a negative regulator of EMT through induction of contact inhibition."}, {"pubmed": 29902837, "text": "TIG1 interacted with DNAJC8 in the cytosol, and this interaction completely blocked DNAJC8-mediated PKM2 translocation and inhibited glucose uptake. Furthermore, increased glycose uptake was observed in cells in which TIG1 was silenced."}, {"pubmed": 30557378, "text": "Study demonstrates that RARRES1 depletion in epithelial cells caused a global increase in lipid synthesis. RARRES1-depleted cells rewire glucose metabolism by switching from aerobic glycolysis to glucose-dependent de novo lipogenesis. Treatment with fatty acid synthase inhibitor reversed the effects of RARRES1 depletion."}, {"pubmed": 31886233, "text": "Investigated whether tazarotene-induced gene 1 protein (TIG1) affects the activity of urokinase plasminogen-type activator, which is negatively regulated by serine peptidase inhibitor Kazal type 2 (SPINK2), potentially preventing epithelial mesenchymal transition and suppressing cell migration and invasion."}, {"pubmed": 32307444, "text": "Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma."}, {"pubmed": 32634130, "text": "Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression."}, {"pubmed": 32918681, "text": "Cathepsin V Mediates the Tazarotene-induced Gene 1-induced Reduction in Invasion in Colorectal Cancer Cells."}, {"pubmed": 34314079, "text": "Tazarotene-induced gene 1 interacts with Polo-like kinase 2 and inhibits cell proliferation in HCT116 colorectal cancer cells."}, {"pubmed": 34556297, "text": "Autocrine and paracrine effects of a novel podocyte gene, RARRES1."}, {"pubmed": 35152215, "text": "Involvement of miR-769-5p/Retinoic Acid Receptor Responder 1 Axis in the Progression of Osteosarcoma: Characterization of Potential Therapeutic Targets."}, {"pubmed": 36353618, "text": "Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma."}, {"pubmed": 37224335, "text": "GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion."}, {"pubmed": 37247911, "text": "TIG1 Inhibits the mTOR Signaling Pathway in Malignant Melanoma Through the VAC14 Protein."}, {"pubmed": 38697478, "text": "Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury."}, {"pubmed": 38898266, "text": "RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma."}, {"pubmed": 38940043, "text": "Tazarotene-induced Gene 1 Induces Melanoma Cell Death by Triggering Endoplasmic Reticulum Stress Response."}], "genomic_pos": {"chr": "3", "end": 158732489, "ensemblgene": "ENSG00000118849", "start": 158696892, "strand": -1}, "genomic_pos_hg19": {"chr": "3", "end": 158450485, "start": 158414681, "strand": -1}, "go": {"BP": {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008285", "qualifier": "involved_in", "term": "negative regulation of cell population proliferation"}, "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0016020", "qualifier": "located_in", "term": "membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 19199708, "qualifier": "located_in", "term": "extracellular exosome"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [21303978, 31886233], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008191", "qualifier": "enables", "term": "metalloendopeptidase inhibitor activity"}]}, "homologene": {"genes": [[8364, 100158540], [9031, 395209], [9544, 703781], [9598, 741650], [9606, 5918], [9913, 510102], [10090, 109222], [10116, 310486]], "id": 2166}, "interpro": [{"desc": "Proteinase inhibitor I47, latexin", "id": "IPR009684", "short_desc": "Prot_inh_latexin"}, {"desc": "Cystatin superfamily", "id": "IPR046350", "short_desc": "Cystatin_sf"}, {"desc": "Latexin N-terminal domain", "id": "IPR048352", "short_desc": "Latexin_N"}, {"desc": "Latexin, C-terminal domain", "id": "IPR048353", "short_desc": "Latexin_C"}, {"desc": "Retinoic acid receptor responder protein 1", "id": "IPR027261", "short_desc": "TIG1"}], "ipi": ["IPI00410240", "IPI00410377"], "map_location": "3q25.32", "name": "retinoic acid receptor responder 1", "other_names": ["RAR-responsive protein TIG1", "latexin-like", "phorbol ester-induced gene 1 protein", "retinoic acid receptor responder (tazarotene induced) 1", "retinoic acid receptor responder protein 1", "tazarotene-induced gene 1 protein"], "pantherdb": {"HGNC": "9867", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1924461", "ortholog_type": "LDO", "panther_family": "PTHR28591", "taxid": 10090, "uniprot_kb": "F6ZIS7"}, {"RGD": "1309509", "ortholog_type": "LDO", "panther_family": "PTHR28591", "taxid": 10116, "uniprot_kb": "Q58NB7"}, {"GeneID": "395209", "ortholog_type": "LDO", "panther_family": "PTHR28591", "taxid": 9031, "uniprot_kb": "Q90YI1"}, {"Ensembl": "ENSGALG00000009594", "ortholog_type": "LDO", "panther_family": "PTHR28591", "taxid": 9031, "uniprot_kb": "F1P181"}, {"ZFIN": "ZDB-GENE-041212-18", "ortholog_type": "O", "panther_family": "PTHR28591", "taxid": 7955, "uniprot_kb": "A0A286Y993"}], "uniprot_kb": "P49788"}, "pfam": ["PF06907", "PF20630"], "pharmgkb": "PA34228", "pharos": {"target_id": 9872, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF255551", "relationship": "is"}, {"id": "GNF255552", "relationship": "is"}, {"id": "GNF255553", "relationship": "is"}, {"id": "GNF255554", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF012208", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF111351", "relationship": "is"}, {"id": "GNF150992", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1"], "protein": ["NP_002879.2", "NP_996846.1", "XP_005247743.4", "XP_054203394.1"], "rna": ["NM_002888.4", "NM_206963.2", "XM_005247686.6", "XM_054347419.1", "XR_008486768.1"], "translation": [{"protein": "NP_996846.1", "rna": "NM_206963.2"}, {"protein": "XP_054203394.1", "rna": "XM_054347419.1"}, {"protein": "NP_002879.2", "rna": "NM_002888.4"}, {"protein": "XP_005247743.4", "rna": "XM_005247686.6"}]}, "reporter": {"HG-U133_Plus_2": ["206391_at", "206392_s_at", "221872_at"], "HG-U95Av2": ["1042_at", "33505_at"], "HTA-2_0": "TC03001949.hg.1", "HuEx-1_0": "2702752", "HuGene-1_1": "8091723", "HuGene-2_1": "16960922"}, "summary": "This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008].", "symbol": "RARRES1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1419273"}, "unigene": "Hs.131269", "uniprot": {"Swiss-Prot": "P49788"}, "wikipedia": {"url_stub": "RARRES1"}}